David H. Mack

The University of Texas MD Anderson Cancer CenterUnited States

Medicine · Health Sciences

23h-index9.0kcitations37works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Cancer-related Molecular Pathways(6), Hepatitis B Virus Studies(5), T-cell and B-cell Immunology(4), Hepatitis C virus research(4), Gene expression and cancer classification(4)

Publications37 total

The preclinical pharmacology of WP1066, a potent small molecule inhibitor of the JAK2/STAT3 pathway
Cancer Research·2006· 12 cited
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.
PubMed·2003· 230 cited
PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
PubMed·2003· 87 cited
Silence of chromosomal amplifications in colon cancer.
PubMed·2002· 150 cited
Proceedings of the National Academy of Sciences·2001· 165 citedOpen Access
Genes & Development·2000· 635 citedOpen Access
Cold Spring Harbor Symposia on Quantitative Biology·2000· 30 cited
B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays [In Process Citation]
ANU Open Research (Australian National University)·2000
Nature Genetics·1999· 2 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Richard Glynne(8), John J. Sninsky(6), Christopher C. Goodnow(6), Kurt Gish(5), Arnold J. Levine(4), Laimonis A. Laimins(4), James I. Healy(4), Daniel A. Notterman(3), Jane Rayner(3), Mark M. Davis(3), Ed Tom(3), Shirley Kwok(2), Renbin Zhao(2), Maureen E. Murphy(2), Yuxin Yin(2), William H. Hoffman(2), Edward Tom(2), Christian Bréchot(2), A.B. Finicle(2), Susan M. Henshall(2)